Healionics Invested 2019

Healionics is a clinical stage company addressing the critical need for improved means of dialysis access in patients with kidney failure. The company is commercializing a synthetic vascular graft called STARgraft with superior patency (ability to maintain blood flow), based on its platform STAR biomaterial technology.  The graft will initially address the urgent need for improved vascular access for hemodialysis patients, with subsequent applications to peripheral artery disease and potentially coronary artery bypass. Healionics is  also developing a device to enable needle-free hemodialysis. www.Healionics.com

Looking for Funding?

VisionTech Partners may be able to help. Through VisionTech Angels and a broad network of investors and business resources, our goal is to help promising ventures succeed. We focus on early stage and early growth technology-based companies in Indiana and the Midwest.

If you have questions or would like more information, Contact Us. If you’re ready to start the process, Submit Your Business Plan using the secure website of Gust, the global platform for angel investing. We look forward to hearing from you!